#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15574	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2117	730.3	0	.	n	.	0	C207T	SNP	207	207	C	433	433	T	812	T,C	387,346	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15574	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2117	730.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	961	C	896	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28012	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	773.5	0	.	n	.	0	T695C	SNP	695	695	T	1039	1039	C	845	C,T	799,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28012	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	773.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2315	2315	C	847	C	786	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28012	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	773.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2389	2389	A	830	A	787	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28012	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	773.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2941	2941	C	875	C	821	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28012	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3612	773.5	0	HET	.	.	.	A1638G,T	.	1638	1638	A	1982	1982	A	888	A,G,T	476,362,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1966	folP	855	855	100.0	folP.l15.c4.ctg.1	1437	135.5	1	SNP	p	R229S	1	.	.	685	687	AGC	930	932	AGC	204;202;203	A;G;C,A	192;187;187,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3217	165.1	1	SNP	p	S91F	1	.	.	271	273	TTC	520	522	TTC	183;185;182	T;T;C	175;177;175	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3217	165.1	1	SNP	p	D95G	1	.	.	283	285	GGC	532	534	GGC	181;179;181	G;G,A;C,T	169;166,1;167,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5340	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3217	165.1	1	SNP	p	G95N	0	.	.	283	285	GGC	532	534	GGC	181;179;181	G;G,A;C,T	169;166,1;167,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1708	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1416	119.8	1	SNP	p	G45D	0	.	.	133	135	GGC	477	479	GGC	219;216;216	G;G;C,T	197;192;197,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	862	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	983	87.0	0	.	n	.	0	A197.	DEL	197	197	A	602	602	A	204	A	190	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2950	165.0	1	SNP	p	D86N	0	.	.	256	258	GAC	579	581	GAC	205;206;206	G;A;C	189;187;193	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2950	165.0	1	SNP	p	R87I	0	.	.	259	261	CGT	582	584	CGT	208;205;204	C;G,A;T	195;190,1;187	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2950	165.0	1	SNP	p	S87R	1	.	.	259	261	CGT	582	584	CGT	208;205;204	C;G,A;T	195;190,1;187	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2950	165.0	1	SNP	p	R87W	0	.	.	259	261	CGT	582	584	CGT	208;205;204	C;G,A;T	195;190,1;187	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4884	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2950	165.0	1	SNP	p	S88P	0	.	.	262	264	TCC	585	587	TCC	207;203;205	T,C;C;C	192,1;191;195	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4414	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2630	166.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1550	1552	GGC	203;200;200	G;G;C,T	192;186;186,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1231	1233	GCC	245;247;245	G;C;C	229;232;230	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1234	1236	ATG	246;247;244	A,G;T;G	229,1;231;228	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1246	1248	ACC	238;238;237	A;C;C	226;228;228	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1246	1248	ACC	238;238;237	A;C;C	226;228;228	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1747	1749	ACC	217;215;216	A;C;C	197;195;200	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1801	1803	GCG	204;204;204	G;C;G	191;192;192	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1801	1803	GCG	204;204;204	G;C;G	191;192;192	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1924	1926	GGT	177;180;179	G;G;T	163;164;161	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1933	1935	AGC	166;164;162	A;G;C	154;150;150	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4136	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2347	175.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1951	1953	CCG	135;139;141	C,G;C,G;G	100,5;103,1;107	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5878	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3094	189.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1644	1646	CCG	200;200;197	C;C;G	168;179;165	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2112	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1866	112.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	599	599	C	146	C	136	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2896	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1560	183.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	460	462	GTT	229;226;225	G;T;T	219;211;213	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2896	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1560	183.9	1	SNP	p	G120K	1	.	.	358	360	AAG	685	687	AAG	247;245;246	A;A;G	233;233;230	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2896	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1560	183.9	1	SNP	p	A121N	1	.	.	361	363	AAC	688	690	AAC	249;247;244	A;A,T;C	236;236,1;233	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2896	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1560	183.9	1	SNP	p	N121D	0	.	.	361	363	AAC	688	690	AAC	249;247;244	A;A,T;C	236;236,1;233	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11258	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4797	233.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1304	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1242	104.5	1	SNP	p	V57M	1	.	.	169	171	ATG	593	595	ATG	271;272;273	A;T;G	248;248;249	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
